Nathalie Bonafé

TLR9-Targeted Biodegradable Nanoparticles as Immunization Vectors Protect against West Nile Encephalitis

Stacey L. Demento, Nathalie Bonafé, Weiguo Cui et al. · The Journal of Immunology · 2010 · 117 citations · Full text

Life Sciences, Biotechnology, Immunology +17

Glyceraldehyde-3-Phosphate Dehydrogenase Binds to the AU-Rich 3′ Untranslated Region of Colony-Stimulating Factor–1 (CSF-1) Messenger RNA in Human Ovarian Cancer Cells: Possible Role in CSF-1 Posttranscriptional Regulation and Tumor Phenotype

Nathalie Bonafé, Maureen Gilmore-Hebert, Nancy L. Folk et al. · Cancer Research · 2005 · 107 citations

Medicine, Cancer Biology, Oncology +15

The Multifunctional Protein Glyceraldehyde-3-Phosphate Dehydrogenase Is Both Regulated and Controls Colony-Stimulating Factor-1 Messenger RNA Stability in Ovarian Cancer

Yi Zhou, Xiaofang Yi, Jha’nae B. Stoffer et al. · Molecular Cancer Research · 2008 · 105 citations · Full text

Medicine, Cancer Biology, Molecular Biology +17

West Nile Virus Envelope Protein Inhibits dsRNA-Induced Innate Immune Responses

Álvaro Arjona‐Sánchez, Michel Ledizet, Karen Anthony et al. · The Journal of Immunology · 2007 · 73 citations

Life Sciences, Immunology, Infectious Diseases +17

Fusion Loop Peptide of the West Nile Virus Envelope Protein Is Essential for Pathogenesis and Is Recognized by a Therapeutic Cross-Reactive Human Monoclonal Antibody

Hameeda Sultana, Harald G. Foellmer, Girish Neelakanta et al. · The Journal of Immunology · 2009 · 47 citations · Full text

Pharmacy, Infectious Diseases, Molecular Biology +16